562 related articles for article (PubMed ID: 16893457)
1. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults.
You D; Becnel D; Wang K; Ripple M; Daly M; Cormier SA
Respir Res; 2006 Aug; 7(1):107. PubMed ID: 16893457
[TBL] [Abstract][Full Text] [Related]
2. A role for airway remodeling during respiratory syncytial virus infection.
Becnel D; You D; Erskin J; Dimina DM; Cormier SA
Respir Res; 2005 Oct; 6(1):122. PubMed ID: 16242038
[TBL] [Abstract][Full Text] [Related]
3. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease.
You D; Siefker DT; Shrestha B; Saravia J; Cormier SA
Respir Res; 2015 Aug; 16(1):91. PubMed ID: 26231396
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
5. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
Lambert AL; Trasti FS; Mangum JB; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365
[TBL] [Abstract][Full Text] [Related]
6. [Combined effects of neonatal Bacillus Calmette-Guerin vaccination and respiratory syncytial infection on experimental asthma in mice].
Li R; Liu EM; Yang XQ; Wang LJ
Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):420-4. PubMed ID: 16836848
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection.
Chi XY; Jiang SJ; Wang J; Wang JP
Asian Pac J Allergy Immunol; 2011 Jun; 29(2):176-80. PubMed ID: 21980833
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.
John AE; Gerard CJ; Schaller M; Miller AL; Berlin AA; Humbles AA; Lukacs NW
Eur J Immunol; 2005 Jan; 35(1):108-16. PubMed ID: 15593301
[TBL] [Abstract][Full Text] [Related]
9. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection differentiates airway dysfunction in the central and peripheral airways in OVA-sensitized mice.
Jiang XB; Huang M; Cui XF; Zhu Y; Yin KS; Yao K
Exp Lung Res; 2012 Nov; 38(9-10):453-62. PubMed ID: 22963501
[TBL] [Abstract][Full Text] [Related]
11. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.
Naessens T; Schepens B; Smet M; Pollard C; Van Hoecke L; De Beuckelaer A; Willart M; Lambrecht B; De Koker S; Saelens X; Grooten J
J Allergy Clin Immunol; 2016 Mar; 137(3):700-9.e9. PubMed ID: 26560044
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
Peebles RS; Sheller JR; Collins RD; Jarzecka AK; Mitchell DB; Parker RA; Graham BS
J Med Virol; 2001 Feb; 63(2):178-88. PubMed ID: 11170055
[TBL] [Abstract][Full Text] [Related]
14. Natural helper cells are associated with the exacerbated airway inflammation seen during RSV reinfection of neonatally primed mice.
Wu J; Hu H; Xu L; Qi F; Bai S; Cui Y; Chai R; Wang D; Liu B
Int Immunopharmacol; 2017 Apr; 45():156-162. PubMed ID: 28219838
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.
John AE; Berlin AA; Lukacs NW
Eur J Immunol; 2003 Jun; 33(6):1677-85. PubMed ID: 12778486
[TBL] [Abstract][Full Text] [Related]
17. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Han J; Jia Y; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2010 Aug; 182(4):455-63. PubMed ID: 20442434
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
Matsuse H; Kondo Y; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Mizuta Y; Kohno S
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):55-60. PubMed ID: 16892782
[TBL] [Abstract][Full Text] [Related]
20. Elevated macrophage inflammatory protein 1α and interleukin-17 production in an experimental asthma model infected with respiratory syncytial virus.
Ishioka T; Yamada Y; Kimura H; Yoshizumi M; Tsukagoshi H; Kozawa K; Maruyama K; Hayashi Y; Kato M
Int Arch Allergy Immunol; 2013; 161 Suppl 2():129-37. PubMed ID: 23711864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
